Sevoflurane

Generic Name
Sevoflurane
Brand Names
Sevorane, Sojourn, Ultane
Drug Type
Small Molecule
Chemical Formula
C4H3F7O
CAS Number
28523-86-6
Unique Ingredient Identifier
38LVP0K73A
Background

Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...

Indication

Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.

Associated Conditions
-
Associated Therapies
General Anesthesia, Induction and Maintenance of General Anesthesia
Clinical Trials
Related News

Interest of Using the Sevoflurane in the Prevention of Newborns Pain

Phase 2
Completed
Conditions
Pain Measurement
Newborn
First Posted Date
2007-01-11
Last Posted Date
2009-01-15
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Target Recruit Count
60
Registration Number
NCT00420693
Locations
🇫🇷

Assistance Publique Hopitaux de Marseille CHU Nord, Marseille, BdR, France

Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)

First Posted Date
2006-06-15
Last Posted Date
2010-06-23
Lead Sponsor
University Hospital, Bordeaux
Target Recruit Count
120
Registration Number
NCT00337051
Locations
🇫🇷

Département d'anesthésie réanimation 1 - Hôpital Pellegrin - CHU de Bordeaux, Bordeaux, France

A Comparison of Two Anaesthetic Methods of Protecting Heart Tissue During Cardiac Surgery

First Posted Date
2005-10-26
Last Posted Date
2005-10-26
Lead Sponsor
Golden Jubilee National Hospital
Target Recruit Count
150
Registration Number
NCT00244283
Locations
🇬🇧

Golden Jubilee National Hospital, Glasgow, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy